Viralgen is happy to kick off the new year at JPM 2023! Come and join us at a special reception we are hosting at JP Morgan Tuesday evening, January 10.

If you have a gene therapy candidate and are looking for support in making this a reality for patients, come find out what we can do to support you from product development through commercial manufacturing up to 2000L leveraging our proprietary platform.

Our CEO Jimmy Vanhove will be joined by Seth Ettenber, Marianne D. De Backer, Holger Weintritt and Jens H. Vogel.

Register now here - Space is limited!